Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Literature
1.
Bostan EE, Borman P, Bodur H, Barca N (2003) Functional disability and quality of life in patients with ankylosing spondylitis. Rheumatol Int 23:121–126PubMed
2.
Bodur H, Ataman Ş, Akbulut L et al (2008) Characteristics and medical management of patients with rheumatoid arthritis and ankylosing spondylitis. Clin Rheumatol 27(9):1119–1125CrossRefPubMed
3.
Onen F, Akar S, Birlik M et al (2005) Prevalence of ankylosing spondylitis in Antalya, Turkey. Clin Rheumatol 24(3):212–214CrossRef
4.
Barkham N, Kong KO, Tennant A et al (2005) The unmet need for anti-tumour necrosis factor therapy in ankylosing spondylitis. Rheumatology 44:1277–1281CrossRefPubMed
5.
Pham T, Landewe R, van der Linden S et al (2006) An international study on starting tumour necrosis factor blocking agents in ankylosing spondylitis. Ann Rheum Dis 65:1620–1625CrossRefPubMed
Metadata
Title
The inadequate anti-tumour necrosis factor (anti-TNF) therapy in patients with ankylosing spondylitis
Authors
Pinar Borman
Figen Ayhan
Esma Ceceli
Publication date
01-11-2010
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 12/2010
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1283-y

Other articles of this Issue 12/2010

Rheumatology International 12/2010 Go to the issue

Case Report

Clinical significance of 18F-fluoro-dexoxyglucose positron emission tomography in patients with adult-onset Still’s disease: report of two cases and review of literatures

Case Report

Periodic fever responds to vitamin B12 treatment

Original Article

Antibodies to human tissue transglutaminase and alterations of vitamin D metabolism in ankylosing spondylitis and psoriatic arthritis

Original Article

The effects of adalimumab and methotrexate treatment on peripheral Th17 cells and IL-17/IL-6 secretion in rheumatoid arthritis patients

Original Article

RETRACTED ARTICLE: Correlation of ESR, C3, C4, anti-DNA and lupus activity based on British Isles Lupus Assessment Group Index in patients of rheumatology clinic

Original Article

Low prevalence of hepatitis B virus infection in patients with systemic lupus erythematosus in southern China
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits